Newsfile Corp

IN THE PRESS

Pharm Country

Humanigen Reports Third Quarter 2022 Financial Results

November 15, 2022

·

6 min read

Marvel Biosciences Lead Drug Candidate MB-204 Demonstrated Superior Anti-Anxiety Activity over FDA-Approved Istradefylline in Head-To-Head Pre-Clinical Studies

November 14, 2022

·

5 min read

Drug Development

NervGen Pharma Completes Dosing in Its Third Multiple Ascending Dose Cohort in Phase 1 Clinical Trial of NVG-291 and Reports Q3 2022 Results

November 14, 2022

·

12 min read

PathogenDx Debuts Octa(TM) AutoPrep Station: a Simple, Easy-To-Use Automated Sample Prep Solution for the Cannabis and Hemp Testing Sector

November 14, 2022

·

4 min read

PreveCeutical Announces Conversion of Debt

November 14, 2022

·

5 min read

Business

Alexander Tokman Joins Izotropic Board of Directors

November 11, 2022

·

4 min read

Deals

Skye Bioscience Closes Acquisition of Emerald Health Therapeutics

November 11, 2022

·

17 min read

GoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders

November 10, 2022

·

1 min read

Pharm Country

Humanigen Announces Participation and Presentation at Jefferies London Healthcare Conference

November 10, 2022

·

3 min read

ScreenPro Announces Non-Brokered Private Placement Financing

November 10, 2022

·

3 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750